Which nonpharmacological pain management technique can be effectively used for chronic pain?

A. Ignore the error if there are no visible critical outcomes:This action is unethical and violates the nursing code of conduct regarding accountability and patient safety. Even "near misses" or errors without harm provide valuable data for systemic improvements in EBP. Concealing errors prevents the implementation of safety protocols designed to protect future patients.

B. Apologize to the patient and promise it won't happen again:While an apology is part of transparent care, it is not a complete clinical response to a medication error. The nurse must follow formal reporting channels to ensure the patient is medically evaluated for adverse effects. Personal promises do not fulfill the legal or institutional requirements for error management.

C. Document the error in the patient's chart but do not communicate it:Charting is necessary, but failing to communicate the error to the healthcare team prevents immediate corrective action. SBAR communication is specifically designed to facilitate the rapid exchange of critical safety information. Silent documentation does not ensure the patient's physiological safety.

D. Report the medication error following the institution's protocol and SBAR format:Utilizing Situation, Background, Assessment, and Recommendation (SBAR) provides a structured, evidence-based method for clear communication. Prompt reporting allows for immediate clinical intervention and contributes to the facility's safety database for quality improvement. This is the highest standard of professional practice.

A. Administer antiviral medication within the first 48 hours of symptom onset:Neuraminidase inhibitors like oseltamivir are most effective when started early to inhibit viral replication and reduce the duration of symptoms. This intervention directly targets the pathogen and can prevent severe complications. Timely administration is a hallmark of evidence-based influenza management.

B. Offer decongestants to suppress cough and reduce fever:Decongestants primarily treat nasal congestion and do not affect viral replication or the underlying disease process. While they may provide temporary symptomatic relief, they are not a priority over antiviral therapy. They also do not possess antipyretic properties for fever reduction.

C. Advise the client to take antihistamines for symptom relief:Antihistamines are indicated for allergic reactions and have little therapeutic value in the management of viral influenza. They may cause unwanted side effects like sedation or drying of the respiratory mucosa. Their use in influenza is generally not supported by clinical guidelines.

D. Prescribe antibiotics to prevent secondary bacterial infections:Influenza is a viral illness, and antibiotics have no effect on viruses. Prescribing them prophylactically is an inappropriate use of medication that contributes to antibiotic resistance. They are only indicated if a secondary bacterial pneumonia is clinically confirmed.